ALK and anaplastic large cell lymphoma: Systemic ALK-positive ALCLs (ALK+ ALCL), associated with the translocation of the Anaplastic Lymphoma Kinase (ALK) oncogene, are considered a distinct entity in the WHO classification [1,2].